Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

OBJECTIVES: To estimate the prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers (PHCPs). DESIGN: Prospective cohort study with 12 months of follow-up. SETTING: Primary care in Belgium. PARTICIPANTS: Any general practitioner (GP) working in primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Adriaenssens, Niels, Scholtes, Beatrice, Bruyndonckx, Robin, Van Ngoc, Pauline, Verbakel, Jan Yvan Jos, De Sutter, An, Heytens, Stefan, Van Den Bruel, Ann, Desombere, Isabelle, Van Damme, Pierre, Goossens, Herman, Buret, Laetitia, Duysburgh, Els, Coenen, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485641/
https://www.ncbi.nlm.nih.gov/pubmed/36123069
http://dx.doi.org/10.1136/bmjopen-2022-065897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485641/
https://www.ncbi.nlm.nih.gov/pubmed/36123069
http://dx.doi.org/10.1136/bmjopen-2022-065897

Ejemplares similares